Suppr超能文献

钆塞酸增强 MRI 肝胆期成像在 HCC 患者中的应用:肝切除、消融或 TACE 治疗前的预后特征。

Hepatobiliary phase of gadoxetic acid-enhanced MRI in patients with HCC: prognostic features before resection, ablation, or TACE.

机构信息

Department of Radiology, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.

Department of Radiology, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.

出版信息

Eur Radiol. 2021 Jun;31(6):3627-3637. doi: 10.1007/s00330-020-07499-w. Epub 2020 Nov 19.

Abstract

OBJECTIVES

Patients with hepatocellular carcinoma (HCC) receiving different treatments might have specific prognostic factors that can be captured in the hepatobiliary phase (HBP) of gadoxetic acid-enhanced magnetic resonance imaging (GA-MRI). We aimed to identify the clinical findings and HBP features with prognostic value in patients with HCC.

METHODS

In this retrospective, single-institution study, we included patients with Barcelona Clinic Liver Cancer very early/early stage HCC who underwent GA-MRI before treatment. After performing propensity score matching, 183 patients received the following treatments: resection, radiofrequency ablation (RFA), and transarterial chemoembolization (TACE) (n = 61 for each). Cox regression models were used to identify clinical factors and HBP features associated with disease-free survival (DFS) and overall survival (OS).

RESULTS

In the resection group, large tumor size was associated with poor DFS (hazard ratio [HR] 4.159 per centimeter; 95% confidence interval [CI], 1.669-10.365) and poor OS (HR 8.498 per centimeter; 95% CI, 1.072-67.338). In the RFA group, satellite nodules on HBP images were associated with poor DFS (HR 5.037; 95% CI, 1.061-23.903) and poor OS (HR 9.398; 95% CI, 1.480-59.668). Peritumoral hypointensity on HBP images was also associated with poor OS (HR 13.062; 95% CI, 1.627-104.840). In addition, serum albumin levels and the prothrombin time-international normalized ratio were associated with DFS and/or OS. Finally, in the TACE group, no variables were associated with DFS/OS.

CONCLUSIONS

Different HBP features and clinical factors were associated with DFS/OS among patients with HCC receiving different treatments.

KEY POINTS

• In patients who underwent resection for HCC, a large tumor size on HBP images was associated with poor disease-free survival and overall survival. • In the RFA group, satellite nodules and peritumoral hypointensity on HBP images, along with decreased serum albumin levels and PT-INR, were associated with poor disease-free survival and/or overall survival. • In the TACE group, no clinical or HBP imaging features were associated with disease-free survival or overall survival.

摘要

目的

接受不同治疗的肝细胞癌 (HCC) 患者可能具有可在钆塞酸增强磁共振成像 (GA-MRI) 的肝胆期 (HBP) 中捕获的特定预后因素。我们旨在确定在 HCC 患者中具有预后价值的临床发现和 HBP 特征。

方法

在这项回顾性、单机构研究中,我们纳入了在治疗前接受 GA-MRI 检查的巴塞罗那临床肝癌非常早期/早期 HCC 患者。在进行倾向评分匹配后,183 名患者接受了以下治疗:切除术、射频消融术 (RFA) 和经动脉化疗栓塞术 (TACE)(每组 61 名)。Cox 回归模型用于确定与无疾病生存率 (DFS) 和总生存率 (OS) 相关的临床因素和 HBP 特征。

结果

在切除术组中,肿瘤较大与 DFS 不良相关 (每厘米风险比 [HR] 4.159;95%置信区间 [CI],1.669-10.365) 和 OS 不良相关 (HR 每厘米 8.498;95%CI,1.072-67.338)。在 RFA 组中,HBP 图像上的卫星结节与 DFS 不良相关 (HR 5.037;95%CI,1.061-23.903) 和 OS 不良相关 (HR 9.398;95%CI,1.480-59.668)。HBP 图像上的肿瘤周围低信号强度也与 OS 不良相关 (HR 13.062;95%CI,1.627-104.840)。此外,血清白蛋白水平和凝血酶原时间国际标准化比值与 DFS 和/或 OS 相关。最后,在 TACE 组中,没有变量与 DFS/OS 相关。

结论

不同的 HBP 特征和临床因素与接受不同治疗的 HCC 患者的 DFS/OS 相关。

关键要点

  • 在接受 HCC 切除术的患者中,HBP 图像上的大肿瘤大小与无疾病生存率和总生存率不良相关。

  • 在 RFA 组中,HBP 图像上的卫星结节和肿瘤周围低信号强度以及血清白蛋白水平和 PT-INR 降低与无疾病生存率和/或总生存率不良相关。

  • 在 TACE 组中,没有临床或 HBP 成像特征与无疾病生存率或总生存率相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验